| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 208.63B | 195.37B | 208.46B | 203.96B | 220.31B | 201.66B |
| Gross Profit | 34.95B | 34.53B | 34.15B | 31.77B | 32.66B | 33.18B |
| EBITDA | 18.71B | 16.69B | 18.54B | 16.82B | 17.71B | 18.50B |
| Net Income | 13.69B | 17.40B | 13.50B | 4.46B | 10.59B | 9.79B |
Balance Sheet | ||||||
| Total Assets | 255.25B | 266.46B | 264.26B | 265.86B | 251.06B | 244.67B |
| Cash, Cash Equivalents and Short-Term Investments | 52.89B | 73.17B | 61.09B | 60.82B | 44.40B | 33.99B |
| Total Debt | 9.43B | 160.00M | 1.01B | 678.00M | 1.40B | 1.41B |
| Total Liabilities | 46.01B | 42.78B | 49.14B | 52.03B | 49.15B | 52.73B |
| Stockholders Equity | 189.82B | 202.65B | 194.82B | 189.71B | 179.81B | 170.48B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 14.36B | 5.93B | 17.81B | 11.16B | -18.58B |
| Operating Cash Flow | 0.00 | 18.76B | 11.31B | 21.52B | 17.34B | -10.64B |
| Investing Cash Flow | 0.00 | -4.00B | -6.74B | -809.00M | -3.16B | -1.99B |
| Financing Cash Flow | 0.00 | -16.41B | -12.51B | -5.36B | -5.09B | -1.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥182.46B | 11.55 | 6.87% | 5.25% | -6.28% | 29.00% | |
71 Outperform | ¥180.09B | 27.66 | 5.06% | 1.80% | 1.69% | 71.95% | |
69 Neutral | ¥739.64B | 7.95 | 10.78% | 4.68% | -4.64% | -21.94% | |
62 Neutral | ¥371.52B | 11.21 | 6.16% | 2.99% | 0.55% | 20.51% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
50 Neutral | ¥2.89T | 175.42 | -0.26% | 4.53% | 15.73% | -95.40% | |
49 Neutral | ¥983.20B | 16.46 | 2.09% | 4.59% | -6.59% | -23.63% |